Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

BACKGROUND: We have evaluated the efficacy of targeting the toxic, oligomeric form of tau protein by passive immunotherapy in a mouse model of synucleinopathy. Parkinson’s disease and Lewy body dementia are two of the most common neurodegenerative disorders and are primarily characterized by the acc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Neurodegener
Autors principals: Gerson, Julia E., Farmer, Kathleen M., Henson, Natalie, Castillo-Carranza, Diana L., Carretero Murillo, Mariana, Sengupta, Urmi, Barrett, Alan, Kayed, Rakez
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5856311/
https://ncbi.nlm.nih.gov/pubmed/29544548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-018-0245-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars